Secondary Logo

Journal Logo

Review Article

How bacterial biofilms affect chronic wound healing: a narrative review

Gajula, Bhargav MBBS; Munnamgi, Sinduja MBBS, MS; Basu, Somprakas MBBS, MS, MSc, FACS

Author Information
International Journal of Surgery: Global Health: March 2020 - Volume 3 - Issue 2 - p e16
doi: 10.1097/GH9.0000000000000016
  • Open

Abstract

It is amazing how a complex event like wound healing is excellently orchestrated by cells and cytokines into a dynamic yet simple process. Four distinct phases such as hemostasis, inflammation, proliferation, and maturation are recognized normally with some temporal overlap and smooth transition1. A number of extrinsic and intrinsic factors seem to influence the process of healing, which under normal circumstances remain in a perfect balance. Persistent insult may lead to delayed healing and a chronic wound formation, which by definition is >6 weeks duration2. Most of these chronic wounds are arrested in the inflammatory phase of healing3. A prolonged inflammatory phase not only delays the onset of proliferation, but high levels of inflammatory mediators and proteases also disrupt the normal process of proliferation and epithelialization3.

Bacteria are ubiquitous in nature and most acute cutaneous wounds would heal in the presence of normal skin flora. Infection starts when the balance between bacterial dose, virulence and immunity tilts in favor of micro-organisms4. Initially it was believed that wound infection is the result of colonization and invasion of planktonic bacteria which reside freely in the environment, and the concept of contamination, colonization and infection as a sequential process was proposed5. However, molecular sampling techniques have shown that chronic wounds harbor a more diverse population of bacteria than was thought of before6 and research in the last couple of decades has established the role of biofilm as a more comprehensive pattern of bacterial influence on chronic wound healing7.

The nature of biofilm

Biofilms are complex colonies of bacterial populations encased in a protective extracellular polymeric substance (EPS), which helps them to adhere to a suitable surface8. Although it can be formed by many species, Pseudomonas aeruginosa and Staphylococcus aureus, the 2 very common microbes responsible for wound biofilm, have been studied the most9. As it is unethical to experimentally generate biofilms in human, most of the present knowledge has been derived from in vitro and animal studies9. A meta-analysis of published data indicates a 78.2% prevalence of biofilms in chronic wounds, making these a significant threat to healing10. In the outer layers of a biofilm, bacteria are mostly aerobic, are actively metabolizing, multiply rapidly and grow easily in cultures. The deeply situated bacteria can survive in low oxygen tension or anaerobic environment, remain dormant for long time and poorly grow in conventional cultures11,12. Definite genetic changes alter their phenotype and result in their poor recognition by the Toll-like receptors (TLR) of innate immune system13. The EPS also provides a physical barrier to immune attack and drugs14,15. The resident bacteria communicate with one another through quorum sensing (QS) molecules9. Some of these also act as bacterial virulence factors and protect the colony against immune attack9. Clinically, a chronic wound with red, friable granulation tissue covered by a slimy layer that comes back after debridement, with increased exudate formation and having evidence of a receding epithelial margin, is likely to be harboring a biofilm16. It may or may not be associated with slough, which is dead necrotic tissue at the wound bed17. Currently biofilm is considered as an independent factor causing delayed wound healing18.

Biofilm delays wound healing

In a diabetic mouse model with P. aeruginosa biofilm Zhao et al19 demonstrated delay in wound healing when compared with the control mice group without biofilm. The wounds with biofilm had thick epidermis and dermis, poorly vascularised matrix and showed evidence of delayed epithelialization. These features closely mimicked those of human chronic wounds, in which matrix becomes unhealthy and epithelial margins get thickened, hyperkeratotic and form epibole20. Subsequently in their later research, Zhao et al3 compared chronic wounds with P. aeruginosa biofilms in diabetic mice with a control group without biofilms in terms of wound closure, histology, gene expression, and blood glucose levels. There was a significant delay in healing (97% vs. 56%) at 4 weeks with an overall average delay of 2 weeks in the biofilm group. A 10-fold increase in interleukin 1β and interleukin 6 (IL-1β, IL-6) and matrix metalloprotease-10 (MMP-10) expressions was observed at fourth week, which indicated persistent inflammatory response in presence of biofilms21. High levels of MMP-10 was suggestive of ongoing collateral matrix damage resulting in delayed healing2. Interestingly, expression of tumor necrosis factor-α (TNF-α), tumor growth factor-β1 (TGF-β1), and vascular endothelial growth factor (VEGF) did not have significant difference between groups. TGF-β and VEGF regulate matrix deposition, angiogenesis, and epithelialization in normal wound healing22 and their levels increase in acute wounds and decrease in chronic wounds21. The above findings indicated that presence of biofilm prolonged inflammatory phase of healing and suppressed proliferative activity. As diabetes increases chance of wound infection and biofilm formation, the diabetic mouse model is ideal for studying in vivo effect of biofilms on chronic wound healing in a shorter time span23. Although the authors did not observe any systemic effect of biofilm, there was significant weight loss in the test group. In absence of systemic effects, weight loss could be due to poor nutrition, which is an independent factor influencing wound healing24 and could have confounded the results.

Roche et al8 studied a Methicillin-resistant S. aureus (MRSA) biofilm in porcine full-thickness dermal wounds. Pig is a preferred model for wound healing research due to its close resemblance with human skin25. They observed significant difference between wound sizes measured at 7 to 14 days of wounding (P<0.0001). A high bacterial bioburden (108 cfu/g of tissue) was observed at the early part of healing (day 4) which subsided to 106 by the 10th day. Similar observation was made by Gurjara et al26 in their study on rabbit ear wound model (discussed later). Of interest was the observation that irrespective of species of bacteria involved, biofilm inhibit wound healing. Therefore, it may be concluded that it is the host response in form of persistent inflammation which is the prime factor responsible in delaying healing.

Gurjala et al26 studied the effect of S. aureus biofilm on rabbit ear wound model, which closely mimics a chronic wound due to exposed perichondrium. The outcome was compared between 2 groups of wounds containing biofilm and planktonic bacteria, respectively, against a control group. A sharp rise in bacterial population was observed till the fourth day, which dropped to 106 cfu/g of tissue, a finding in concordance with that of Roche et al8. This was probably due to initial clearance of the planktonic bacteria leaving behind the more stable biofilm population, indicating a steady state the biofilm is thought to maintain with its host7. Significant difference in the epithelial and granulation gaps were noted on the 12th day. The large epithelial gaps in the biofilm group were likely due to poor keratinocyte migration. Kintarak et al27 demonstrated that biofilm staphylococci express a cell surface-related fibronectin binding protein. For keratinocyte migration to happen, fibronectin receptors on keratinocytes need to bind with fibronectin in the matrix28. The fibronectin binding protein of the biofilm bacteria can thus directly inhibit epithelialization. Interestingly cartilage necrosis was found in the more acute planktonic group as compared with biofilm group, an observation which strengthens the view that biofilms tend to maintain a steady state interaction with the host. This was also supported by the observation that a significantly low-grade host response, measured through IL-1β and TNF-α, was elicited by the biofilms compared with the active infection by the planktonic form. However, the authors did not find any weight loss in the animals with biofilms as opposed to the diabetic mouse model of Zhao et al19.

A number of other animal studies have also confirmed the delay in healing caused by wound biofilms9,15,18,29. Schaber et al15 demonstrated a delay in reepithelialization of thermal cutaneous wounds in mouse when infected with P. aeruginosa biofilms. A significant observation was the development of Pseudonomas microcolonioes around capillaries. The authors concluded that these may be the starting point of systemic invasion frequently seen in burn patients. However, according to Wolcott et al7, this finding probably suggests proximity of bacteria to a nutrition source as red corpuscles and exudate from blood vessels is a principal source of protein and iron for the bacteria.

The significance of the study by Seth et al9 lies in the use of a polymicrobial biofilm model containing Staphylococcus and Pseudomonas on rabbit ear wounds. Both species survived until the wounds were harvested on the 12th day. The authors observed a significant upregulation of IL-1β and TNF-α in the mixed population than in the pure groups. When the wild type Staphylococcal strain was replaced with a mutant one, the cytokine expression decreased. Therefore, it can be argued that inflammatory response to a polymicrobial biofilm is additive in nature and the presence of multiple species is not mutually repressive. Moreover, the epithelial gaps were significantly bigger in the polymicrobial group indicating that effect of biofilm on wound healing is influenced by the polymicrobial nature of resident flora in the wound. However, it needs to be seen whether the same holds true in human wounds.

Effect of biofilm on various phases of wound healing

In vitro models have been a mainstay of biofilm research. They project a pure picture of bacteria and immune cell interaction, but lack the overall effect of a fully formed complex biofilm on an organized immune system. Although biofilms affect all phases of wound healing directly or indirectly, maximum insult occurs in the inflammatory phase7. Jensen et al30 compared the effect of polymorphonuclear cells (PMN) on P. aeruginosa biofilm and planktonic bacteria in vitro. PMN-induced killing was measured by chemiluminescence assay. The response of PMN cells was significantly lesser in the biofilm group as compared with the planktonic group, indicating that the PMN cell action decreases in presence of biofilm bacteria. However, they were unable to measure the percentage of biofilm bacteria which actually came in contact with the PMN cells.

Jensen et al31 in their in vitro study observed that rhamnolipids, a QS molecule produced by P. aeruginosa, rapidly necroses PMN cells when incubated with the biofilm supernatant. On the basis of this observation it may be assumed that PMN activity can be inhibited by various biomolecules elaborated by the bacteria and a direct cell to cell interaction does not. Rhamnolipids can also inhibit phagocytosis by acting as a protective shield29. McClure and Schiller32 reported that rhamnolipids caused macrophage membrane distortion and inhibited bacterial binding, phagocytosis, and destruction of phagocytosed bacteria. Not only fewer macrophages were able to bind bacteria, but the number of bacteria cleared by each cell was also decreased. Schooling and Beveridge33 observed that lipopolysaccharide (LPS) from gram negative bacteria induces chemotaxis and stimulates neutrophils to produce chemokines, but also affects neutrophil function by altering membrane-related phosphatidylserine residues. The above observations confirm that multiple bacterial cell products in biofilms can strongly affect various cellular functions in the inflammatory phase.

Because of altered phenotype and metabolism, the biofilm bacteria are less susceptible to killing by immune cells. Two possible outcomes of a biofilm have been described. If the bacterial virulence is very high, tissue necrosis takes place for deriving nutrition34. In the other situation, after a steady-state is reached, low grade virulence factors such as bacterial DNA and cell wall LPS induce chemotaxis, PMN infiltration and upregulation of proinflammatory cytokines35. This maintains a state of hyper-inflammation and exudate formation, which provides continued nutrition to the bacteria. At the same time bacterial death is decreased by inhibition of opsonization and trapping of cytokines by the EPS3. Normally the neutrophils, after phagocytosis, undergo apoptosis and are cleared by the macrophages36. After phagocytosis of biofilm bacteria, the neutrophils become poorly recognizable by macrophages and finally disintegrate37. This liberates elastase, MMPs and proinflammatory cytokines, which further block macrophage recognition of neutrophils and precipitate neutrophil death, thus setting a vicious cycle. Elastase and MMPs also degrade the underlying matrix38. The relative anaerobic condition in the depth of biofilm inhibits respiratory burst of neutrophil7. Moreover, short chain fatty acids liberated by Bacteroides can inhibit lysozyme release by neutrophils thus inhibiting both aerobic and anaerobic bacterial death, a mechanism which suggests that different species of bacteria mutually help one another in a biofilm39. Thus, the biofilm indirectly controls host immune system by inhibiting a switch from innate to adaptive immunity, milks the host tissue of nutrition and arrests the wound in an inflammatory state, all of which lead to delayed healing13.

Keratinocyte migration is also inhibited in presence of biofilms. Normally, in an acute wound, reepithelialization starts within few hours of injury1. In a chronic wound, despite active proliferation at the wound margins, keratinocytes fail to migrate40. Although a number of causes such as hypoxia41, increased protease activity42, senescence of fibroblasts43 have been identified, the exact causes related to biofilm is still speculative. Kirker and colleagues studied the effect of Staphylococcal biofilm on human keratinocyte migration in vitro using scratch assay and observed a significant decrease in keratinocyte migration and survival as well as morphologic changes in cell shape, breakdown of actin skeleton and nuclear fragmentation, all of which point toward toxic effects of biofilm bacteria on keratinocytes44. However, it was not known whether lower survival was the cause of decreased migration.

Loryman and Mansbridge45 reported significant decrease of keratinocyte migration and increased apoptosis in presence of LPS from biofilm-derived P. aeruginosa and Escherichia coli. But the migration inhibition was reversed when blocking antibodies to TLR-2 and TLR-4 were used, confirming that the inhibition of migration is mediated through TLR receptors. In a splinted mouse cutaneous ulcer model, Schierle et al18 observed significant delay in reepithelialization in presence of Staphylococcal biofilm. The effect was reversed by adding RNAIII inhibitory peptide, a QS inhibitor. Their result confirmed that bacterial QS molecule is the cause of delay in epithelial resurfacing. In another article by Marano et al46, the effect of Staphylococcus and Pseudomonas biofilm broth on cellular toxicity, proliferation and migration of keratinocytes were studied in vitro. The biofilm conditioned broths of both species inhibited cellular proliferation, and both were cytotoxic in higher concentrations. But only S. aureus conditioned broth inhibited cellular migration. On proteomic analysis, it was found that the effect of Staphylococcus was mediated by a protein, whereas that of Pseudomonas was mediated by a small molecule. Moreover, they were able to isolate a number of proteins and enzymes with putative effects on delayed healing. Thus, it seems that not one but a number of bacterial products in biofilm act as inhibitors to keratinocyte proliferation and migration and thus lead to delayed wound resurfacing.

Conclusions

Our knowledge of biofilm and its influence on wound healing, especially chronic wound healing is still evolving. A number of observations generated from experiments in laboratory or in animal models have helped to understand the pathogenesis of delayed healing in chronic wounds colonized with biofilm. But, as the biofilm itself is highly complex, individual bacterial model is insufficient to simulate a true complex clinical picture. Lack of human experiments due to ethical reasons provides little knowledge of its effects in chronic wounds. It is believed that the basic pathophysiology of biofilm involves manipulation of host inflammatory response, and turning it to advantage in deriving a continuous source of nutrition. The inability of the host immune system to inhibit hyperinflammation and induce conversion of innate immune response to an adaptive immune response leads to arrest of wound healing in the inflammatory phase, and progression to the proliferative phase and epithelialization. The biofilm thus affects all phases of wound healing directly or indirectly, and is at present considered an independent factor in delaying normal wound healing.

Ethical approval

None.

Sources of funding

None.

Author contribution

B.G.: Literature search. S.M.: Drafted the manuscript. S.B.: Drafted the manuscript and revised it for intellectual content.

Conflict of interest disclosures

The authors declare that they have no financial conflict of interest with regard to the content of this report.

Research registration unique identifying number (UIN)

None.

Guarantor

Somprakas Basu.

References

1. Ganapathy N, Venkataraman SS, Daniel R, et al. Molecular biology of wound healing. J Pharm Bioallied Sci 2012;4(suppl 2):S334–S337.
2. Fonder MA, Lazarus GS, Cowan DA, et al. Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol 2008;58:185–206.
3. Zhao G, Usui ML, Underwood RA, et al. Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model. Wound Repair Regen 2012;20:342–52.
4. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001;14:244–69.
5. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis 2004;17:91–96.
6. Dowd SE, Sun Y, Secor PR, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008;8:43.
7. Wolcott RD, Rhoads DD, Bennett ME, et al. Chronic wounds and the medical biofilm paradigm. J Wound Care 2010;19:45–46; 48–50, 52–53.
8. Roche ED, Renick PJ, Tetens SP, et al. Increasing the presence of biofilm and healing delay in a porcine model of MRSA-infected wounds. Wound Repair Regen 2012;20:537–43.
9. Seth AK, Geringer MR, Hong SJ, et al. Comparative analysis of single-species and polybacterial wound biofilms using a quantitative, in vivo, rabbit ear model. PLoS One 2012;7:e42897.
10. Malone M, Bjarnsholt T, McBain AJ, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care 2017;26:20–25.
11. Werner E, Roe F, Bugnicourt A, et al. Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2004;70:6188–96.
12. Cornforth DM, Dees JL, Ibberson CB, et al. Pseudomonas aeruginosa transcriptome during human infection. Proc Natl Acad Sci U S A 2018;115:E5125–E5134.
13. Wolcott RD, Rhoads DD, Dowd SE. Biofilms and chronic wound inflammation. J Wound Care 2008;17:333–41.
14. Branda SS, Vik S, Friedman L, et al. Biofilms: the matrix revisited. Trends Microbiol 2005;13:20–26.
15. Schaber JA, Triffo WJ, Suh SJ, et al. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signalling. Infect Immun 2007;75:3715–21.
16. Lenselink E, Andriessen A. A cohort study on the efficacy of a polyhexanide-containing biocellulose dressing in the treatment of biofilms in wounds. J Wound Care 2011;20:536–9.
17. Hurlow J, Bowler PG. Clinical experience with wound biofilm and management: a case series. Ostomy Wound Manage 2009;55:38–49.
18. Schierle CF, De la Garza M, Mustoe TA, et al. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen 2009;17:354–9.
19. Zhao G, Hochwalt PC, Usui ML, et al. Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds. Wound Repair Regen 2010;18:467–77.
20. Moffatt C. Wound bed preparation for Venous Ulcers. Wound Bed Preparation in Practice. EWMA Position Document, MEP, London; 2004.
21. Tomic-Canic M, Agren MA, Alvarez OMRovie DT, Maibach H. Epidermal repair and chronic wounds. The Epidermis in Wound Healing. New York, NY: CRS Press; 2004:26–57.
22. Cox L. Present angiogenesis research and its possible future implementation in wound care. J Wound Care 2003;12:225–8.
23. Jacobson KS. Sources of surgical infection. Surgery 1999;17:126–30.
24. Osak M. Nutrition and wound healing. Plast Surg Nurs 1993;13:29–36.
25. Sullivan TP, Eaglstein WH, Davis SC, et al. The pig as a model for human wound healing. Wound Repair Regen 2001;9:66–76.
26. Gurjala AN, Geringer MR, Seth AK, et al. Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen 2011;19:400–10.
27. Kintarak S, Nair SP, Speight PM, et al. A recombinant fragment of the fibronectin-binding protein of Staphylococcus aureus inhibits keratinocyte migration. Arch Dermatol Res 2004;296:250–7.
28. Clark RA, Lanigan JM, DellaPelle P, et al. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound re-epithelialisation. J Invest Dermatol 1982;79:264–9.
29. Seth AK, Geringer MR, Gurjala AN, et al. Understanding the host inflammatory response to wound infection: an in vivo study of Klebsiella pneumoniae in a rabbit ear wound model. Wound Repair Regen 2012;20:214–25.
30. Jensen ET, Kharazmi A, Lam K, et al. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun 1990;58:2383–5.
31. Jensen PØ, Bjarnsholt T, Phipps R, et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiol 2007;153:1329–38.
32. McClure CD, Schiller NL. Effects of Pseudomonas aeruginosa rhamnolipids on human monocyte-derived macrophages. J Leukoc Biol 1992;51:97–102.
33. Schooling SR, Beveridge TJ. Membrane vesicles: an overlooked component of the matrices of biofilms. J Bacteriol 2006;188:5945–57.
34. Gabillot-Carre M, Roujeau JC. Acute bacterial skin infections and cellulitis. Curr Opin Infect Dis 2007;20:118–23.
35. Bayles KW. The biological role of death and lysis in biofilm development. Nat Rev Microbiol 2007;5:721–6.
36. Greenhalgh DG. The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998;30:1019–30.
37. Guzik K, Bzowska M, Smagur J, et al. A new insight into phagocytosis of apoptotic cells: proteolytic enzymes divert the recognition and clearance of polymorphonuclear leukocytes by macrophages. Cell Death Differ 2007;14:171–82.
38. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg 1998;25:341–56.
39. Eftimiadi C, Buzzi E, Tonetti M, et al. Short-chain fatty acids produced by anaerobic bacteria alter the physiological responses of human neutrophils to chemotactic peptide. J Infect 1987;14:43–53.
40. Mustoe TA, O’Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 2006;117(suppl):35S–41S.
41. Dalton SJ, Mitchell DC, Whiting CV, et al. Abnormal extracellular matrix metabolism in chronically ischemic skin: a mechanism for dermal failure in leg ulcers. J Invest Dermatol 2005;125:373–9.
42. Ladwig GP, Robson MC, Liu R, et al. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 2002;10:26–37.
43. Harding KG, Moore K, Phillips TJ. Wound chronicity and fibroblast senescence—implications for treatment. Int Wound J 2005;2:364–8.
44. Kirker KR, Secor PR, James GA, et al. Loss of viability and induction of apoptosis in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair Regen 2009;17:690–9.
45. Loryman C, Mansbridge J. Inhibition of keratinocyte migration by lipopolysaccharide. Wound Repair Regen 2008;16:45–51.
46. Jeffery Marano R, Jane Wallace H, Wijeratne D, et al. Secreted biofilm factors adversely affect cellular wound healing responses in vitro. Sci Rep 2015;5:13296.
Keywords:

Biofilm; Chronic wound; Delayed healing; Wound healing; Bacteria; Biofilm bacteria

Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of IJS Publishing Group Ltd.